Key result
CMR-derived LV filling pressure, LA volume, and biventricular function predict major events, unlike pathogenic gene mutations.
Why the study?
Dilated cardiomyopathy and non-dilated left ventricular dysfunction comprise patients with heterogeneous genetics and prognosis, prompting investigation into their genotype-phenotype relationships and outcomes.
Cohort (n=249)
In patients with non-ischaemic cardiomyopathy, clinical and CMR-derived parameters are predictors of poor prognosis, whereas the presence of pathogenic gene mutations is not.
Answers are grounded in this paper and cite their sources.
CMR parameters may aid risk stratification in non-ischaemic cardiomyopathy; leaves open the prognostic role of genetic testing.
BACKGROUND Dilated cardiomyopathy (DCM) and non-dilated left ventricular (LV) dysfunction (NDLVD) comprise patients with heterogeneous genetics and prognosis. This study aimed to investigate genotype-phenotype relationship and prognosis in DCM and NDLVD. METHODS Patients with a comprehensive clinical, genetic and CMR assessment, with LV ejection fraction (LVEF) <57% were included. Patients were categorized into DCM or NDLVD according to LV dilation (end-diastolic volume >96 ml/m2 in women, >105 ml/m2 in men). Patients with coronary artery disease, valvular, congenital, hypertrophic, inflammatory or infiltrative disease were excluded. The primary endpoint was a composite of cardiovascular death, sustained ventricular arrhythmias or appropriate defibrillator intervention. The secondary endpoint included also heart failure hospitalizations. RESULTS The cohort included 249 patients (age 53±14 years, 166 males) with median LVEF 45% (IQ range 33-51%), divided in 143 DCM and 106 NDLVD patients. Pathogenic/likely pathogenic mutations were present in 67 (27%), but were neither associated with phenotype, nor with prognosis. During a 72 (35-119) month follow-up, 54 patients (22%) experienced the composite event, 67 patients (27%) the secondary endpoint. At multivariate analysis, male sex, disease duration, natriuretic peptides, non-sustained ventricular arrhythmias, LVEF, left atrial volume and CMR-derived LV filling pressure predicted the primary endpoint (p<0.05). Moreover, disease duration, natriuretic peptides, non-sustained ventricular arrhythmias, right ventricular ejection fraction and CMR-derived LV filling pressure predicted the secondary endpoint (p<0.05). CONCLUSIONS In this cohort of patients with non-ischaemic cardiomyopathy, biventricular systolic function, left atrial volume and CMR-derived LV filling pressure were predictors of poor prognosis, while gene mutations were not.
No takes yet. Share an insight, caveat, or question.
Bellisario et al. (2026) conducted a cohort in Dilated cardiomyopathy and non-dilated left ventricular dysfunction (n=249). Dilated cardiomyopathy (DCM) vs. Non-dilated left ventricular dysfunction (NDLVD) was evaluated on Composite of cardiovascular death, sustained ventricular arrhythmias or appropriate defibrillator intervention (p=<0.05). CMR-derived LV filling pressure, left atrial volume, and biventricular systolic function predicted the primary composite endpoint, whereas pathogenic gene mutations did not.
Synapse has enriched 10 related papers. Consider them for comparative context: